The Indian Central Drugs Standard Control Organisation’s Drug Controller General (DCGI) on October 22, informed that Russia’s vaccine against COVID-19, Sputnik V will be tested on 100 Indian volunteers.
The pharmaceutical giant Dr Reddy’s Laboratories have been granted permission by the DCGI to conduct the tests. However, the company will determine the date and time for the tests.
A government official stated that Dr Reddy’s Lab has said to include 100 subjects in phase 2 clinical trial while for phase 3, it would take 1,400 subjects. Adding further, the official said, “Once the pharma company would submit the safety and immunogenicity data of phase 2, it would be analysed by the expert panel and then they can proceed for the phase 3 trial.”